Stem Cell Therapy and ‘Curing Blindness’
The London Project to Cure Blindness
Age-Related Macular Degeneration (ARMD) is the leading cause of blindness in people over the age of 60 in the western world.
It is a debilitating disease associated with aging that results in the loss of central vision, making it increasingly difficult to see objects clearly. Common everyday tasks become much harder, for example reading a book, seeing people’s faces and driving.
With our aging population, the prevalence of ARMD is set to increase, therefore research is underway into ways to improve a sufferers’ quality of life in the future.
The London Project to Cure Blindness is a collaborative project between the University College London and Moorfields Eye Hospital. Its guiding belief is that stem cell therapies have the greatest chance of preventing blindness and potentially restoring sight.
The video below is a BBC interview with Professor Pete Coffey of the University College London Institute for Ophthalmology, talking about ARMD and this ground-breaking research.Tags: blindness cured, cure blindness, eyesey, london project, stem cell therapy